AMN director sells 3,681 shares under 10b5-1 plan

AMN Healthcare Services director Mark G. Foletta, through The Foletta Family Trust, reported open-market sales of a total of 3,681 shares of AMN common stock on June 15, 2026.

Rhea-AI Filing Summary

AMN Healthcare Services director Mark G. Foletta, through The Foletta Family Trust, reported open-market sales of a total of 3,681 shares of AMN common stock on June 15, 2026. The trust sold 2,000 shares at a weighted average price of $31.069 and 1,681 shares at a weighted average price of $31.067, in multiple trades within disclosed price ranges. Both sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. After these transactions, indirect holdings reported for the trust were 19,917 shares in one line and 17,917 shares in another.

Insider Trade Summary 10b5-1

Net Seller: 3,681 shares

Net Sell 2 txns

Insider FOLETTA MARK G

Role Director

Sold 3,681 shs ($114K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,681	$31.067	$52K
Sale	Common Stock	2,000	$31.069	$62K

Holdings After Transaction: Common Stock — 17,917 shares (Indirect, by Trust)

Footnotes (5)

1. F1. The sale of 1,681 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan").
2. F2. The price reported in this row represents a weighted average price of $31.067 per share. These shares were sold in multiple transactions at prices ranging from $30.86 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. F3. Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the Reporting Person is a trustee.
4. F4. The sale of 2,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan").
5. F5. The price reported in this row represents a weighted average price of $31.069 per share. These shares were sold in multiple transactions at prices ranging from $30.82 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Total shares sold: 3,681 shares Block 1 shares sold: 2,000 shares Block 2 shares sold: 1,681 shares +4 more

7 metrics

Total shares sold 3,681 shares Open-market sales on June 15, 2026

Block 1 shares sold 2,000 shares Weighted average price $31.069 per share

Block 2 shares sold 1,681 shares Weighted average price $31.067 per share

Post-transaction holdings (line 1) 19,917 shares Indirectly held by The Foletta Family Trust

Post-transaction holdings (line 2) 17,917 shares Indirectly held by The Foletta Family Trust

Price range block 1 $30.82–$31.22 Trades within this range for 2,000-share sale

Price range block 2 $30.86–$31.22 Trades within this range for 1,681-share sale

Key Terms

Rule 10b5-1 trading plan, weighted average price, indirect ownership, trustee, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sale of 1,681 shares ... was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in this row represents a weighted average price of $31.067 per share."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

indirect ownership financial

"direct_or_indirect: "I", nature_of_ownership: "by Trust""

trustee financial

"Shares are held by The Foletta Family Trust ... with respect to which the Reporting Person is a trustee."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

open-market sale financial

"transaction_action: "open-market sale", transaction_code_description: "Sale in open market or private transaction""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AMN (AMN) report for Mark G. Foletta?

AMN reported that director Mark G. Foletta, through The Foletta Family Trust, sold 3,681 shares of common stock in open-market transactions on June 15, 2026. These were indirect sales by the trust, not direct personal trades.

How many AMN (AMN) shares were sold and at what prices?

The trust sold 2,000 AMN shares at a weighted average price of $31.069 and 1,681 shares at a weighted average price of $31.067. Each block was executed across multiple trades within narrow price ranges around those averages.

Were the AMN (AMN) insider sales made under a Rule 10b5-1 plan?

Yes. Both the 2,000-share and 1,681-share AMN stock sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2026. Such plans pre-schedule trades to reduce discretion over timing.

Who actually holds the AMN (AMN) shares involved in this Form 4?

The shares are held by The Foletta Family Trust DTD 1/30/2015, for which Mark G. Foletta serves as trustee. The Form 4 classifies these as indirect holdings by trust, rather than shares held directly in his own name.

How many AMN (AMN) shares did the trust report after these sales?

After the reported transactions, one line in the filing shows 19,917 AMN shares indirectly held by the trust, and another shows 17,917 shares. These figures reflect share balances following each respective sale entry.

What price ranges were involved in the AMN (AMN) insider sales?

For the 1,681-share sale, individual trades ranged from $30.86 to $31.22. For the 2,000-share sale, trades ranged from $30.82 to $31.22. Weighted average prices of $31.067 and $31.069 were reported for those blocks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/17/2026 - 07:31 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOLETTA MARK G

(Last) (First) (Middle)

2999 OLYMPUS BOULEVARD

SUITE 500

(Street)

DALLAS TEXAS 75019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [ AMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		S(1)		1,681	D	$31.067(2)	19,917	I	by Trust(3)
Common Stock	06/15/2026		S(4)		2,000	D	$31.069(5)	17,917	I	by Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of 1,681 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan").

2. The price reported in this row represents a weighted average price of $31.067 per share. These shares were sold in multiple transactions at prices ranging from $30.86 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

3. Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the Reporting Person is a trustee.

4. The sale of 2,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan").

5. The price reported in this row represents a weighted average price of $31.069 per share. These shares were sold in multiple transactions at prices ranging from $30.82 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Mark G. Foletta	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)